Work

A patent review of mitogen-activated protein kinase-interacting kinases (MNKs) modulators (2019–present)

Year: 2024

Type: review

Source: Expert Opinion on Therapeutic Patents

DOI: 10.1080/13543776.2024.2446225

Authors: Qiang Li, Xiang Chen, Mingzhi Su, Yue-Wei Guo, Xin Jin

Institutions: Shandong First Medical University, Shanghai University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, National Key Research and Development Program of China

Awards: G3550630099, G6564606979, G809333991

OpenAlex ID: W4405663030

FWCI: 0.082

Cites: 25

Cited by: 2

Related to: 10